America’s FDA Approves First New Drug for Schizophrenia in Over 30 Years
Thursday America’s Food and Drug Administration approved Cobenfy, the first new drug to treat people with schizophrenia in more than 30 years. Most schizophrenia medications, broadly known as antipsychotics, work by changing dopamine levels, a brain chemical that affects mood, motivation, and thinking [according to Jelena Kunovac, MD, a board-certified Read more…





